According to Aspen Pharmacare's latest financial reports the company's current revenue (TTM ) is โน211.59 Billion. In 2024 the company made a revenue of โน211.59 Billion an increase over the revenue in the year 2023 that were of โน184.64 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน211.59 B | 14.6% |
2023 | โน184.64 B | -8.95% |
2022 | โน202.79 B | -10.51% |
2021 | โน226.59 B | 36.72% |
2020 | โน165.73 B | -23.1% |
2019 | โน215.52 B | -9.69% |
2018 | โน238.64 B | -11.51% |
2017 | โน269.67 B | 30.72% |
2016 | โน206.29 B | -18.63% |
2015 | โน253.54 B | 6.94% |
2014 | โน237.07 B | 42.19% |
2013 | โน166.73 B | 4.29% |
2012 | โน159.86 B | 2.14% |
2011 | โน156.51 B | 47.37% |
2010 | โน106.20 B | 13.94% |
2009 | โน93.20 B | 82.69% |
2008 | โน51.01 B | 3.13% |
2007 | โน49.47 B | 17.65% |
2006 | โน42.04 B | 19.4% |
2005 | โน35.21 B | 15.47% |
2004 | โน30.49 B | 19.16% |
2003 | โน25.59 B |